You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: September 27, 2023

Orange Book PDF for Edition 20, Supplement 12

Approved Drug Products with Therapeutic Equivalence Evaluations

Email this page to a colleague

Why are we offering FDA Orange Book PDFs for Free?

We've seen websites charging more than $6,000 for copies of the FDA Orange Book, and we simply can't understand why.

For less than $100 in FOI processing fees we were able to collect extensive archives of the FDA Orange Book as a service to users of DrugPatentWatch. And, because these books are in such high demand, yet so easy to acquire, we decided to make them available for free.

Please help spread the word.

Tell your friends about this free resource

Download this PDF

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.